Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Thumbnail

CT reveals HIV patients living with higher levels of dangerous coronary plaque

For radiologists, the findings suggest CCTA should also include quantifying coronary plaques by subtype, researchers explained in Radiology.

Thumbnail

TEER still beneficial for heart failure patients with an elevated mitral valve gradient

Researchers explored data from the COAPT trial, sharing their findings in JACC: Cardiovascular Interventions.

Thumbnail

Red meat linked to heart damage—expert says it ‘seems sensible’ to limit intake

Researchers relied on imaging data from nearly 20,000 UK Biobank participants to reach their conclusion.

M&A mergers and acquisitions business deal

Endologix acquires medical device company focused on peripheral artery disease

PQ Bypass, the company Endologix acquired, has gained significant attention for its Detour platform, an investigational treatment for percutaneous femoral-popliteal bypass.

Thumbnail

New guidelines focus on the management of heart failure patients with secondary mitral regurgitation

The Heart Failure Association, European Association of Cardiovascular Imaging, European Heart Rhythm Association and European Association of Percutaneous Cardiovascular Interventions all collaborated on the position statement.

Thumbnail

AI model predicts a patient’s risk of death—and all it needs is an X-ray

The AI model, a convolutional neural network, could help age-based risk scores be more accurate than ever before.

CT perfusion a key tool for evaluating stroke patients—but utilization remains low

The analysis, published in Circulation: Cardiovascular Quality and Outcomes, included data from more than 87,000 Medicare patients. 

Championing Alternative PAD Access in the Office-based Lab

Sponsored by Terumo

Improving access is at the center of a pair of new trends in treating peripheral artery disease (PAD). First is the office-based lab (OBL) expanding access to more PAD patients needing therapy, and the second is physicians more often choosing alternative access such as radial, tibial or pedal to treat those patients. Why now?